Bone Marrow News and Research

RSS

Bone Marrow is the soft, sponge-like tissue in the center of most bones. It produces white blood cells, red blood cells, and platelets.

New therapeutic approach for treating patients with compromised immune systems

A young woman who had been hospitalized for three months straight due to debilitating, recurrent infections with no apparent underlying cause was finally able to go home thanks to a Massachusetts General Hospital (MGH) team who put their heads together, discovered a root of the problem, and developed a novel treatment strategy just for her.

23 Oct 2020

New method for producing FTVI enzyme can help improve cord blood transplants

A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.

22 Oct 2020

New vaccine targeting toxic Aβ may offer clinical benefit in treating Alzheimer's disease

Our immune system's capacity to mount a well-regulated defense against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65.

20 Oct 2020

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

16 Oct 2020

Two studies show the benefit of collaborative research on childhood blood disorders

When a child has a rare blood disorder, clinicians can struggle to find the best diagnostic and treatment methods.

15 Oct 2020

Study uncovers the mechanism behind bone marrow failure in Fanconi anemia

Fanconi anaemia (FA) is a genetic disease affecting small children characterized by bone-marrow failure, developmental abnormalities and predisposition to multiple forms of cancer.

14 Oct 2020

Researchers receive $11 million grant to study factors involved in multi-drug resistant infections

A study aimed at better understanding why some critically ill patients develop multidrug-resistant infections is underway by researchers at The University of Texas Health Science Center at Houston.

14 Oct 2020

CAR NKT cells offer a promising approach to combat hard-to-treat solid tumors

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with cancer.

13 Oct 2020

Too little sugar is the cause of perforated bones

Bone marrow cancer is currently an incurable disease that affects about 400 people in Norway every year. Professor Therese Standal at NTNU has now found an important reason for bone destruction in people with this disease.

9 Oct 2020

Researchers drastically reduce the harvest period of stem cell sheets

Stem cells are cell factories that constantly divide themselves to create new cells. Implanting stem cells in damaged organs can regenerate new tissues.

8 Oct 2020

New biomarker may help identify patients at risk for graft-versus-host disease after stem cell transplants

A recent report published in Science Translational Medicine by MUSC Hollings Cancer Center investigator Sophie Paczesny, M.D., Ph.D., sheds light on immune cell biomarkers that may reveal which patients are most at risk for graft-versus-host disease (GVHD), a life-threatening condition that can arise after hematopoietic stem cell transplantation (HSCT) for treatment of liquid cancers such as leukemia.

7 Oct 2020

New drug offers a promising treatment for neuroblastoma

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine.

6 Oct 2020

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

A new study published on the preprint server bioRxiv* aimed to investigate the impacts of COVID-19 on people with various illnesses. Specifically, the researchers at the Rockefeller Cancer Institute, and the University of Arkansas for Medical Sciences wanted to see the effects of COVID-19 on patients with cancer and other infectious diseases.

6 Oct 2020

800 million children have high lead levels in their blood

As many as 800 million children have dangerously high lead values in their blood. The neurotoxin can cause permanent brain damage.

1 Oct 2020

Combinational therapy with antibiotics and stem cells effectively treats bone infections

Bone infections caused by implants are difficult to treat and usually require a prolonged course of antibiotic treatment.

1 Oct 2020

$9.1 million NCI grant renewal will support researchers studying retrovirus cancer models

The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and The Ohio State University College of Veterinary Medicine have been awarded a five-year, $9.1 million grant Program Project Grant renewal from the National Cancer Institute.

1 Oct 2020

Bone Marrow News and Research

Further Reading

New therapeutic approach for treating patients with compromised immune systems

New method for producing FTVI enzyme can help improve cord blood transplants

New vaccine targeting toxic Aβ may offer clinical benefit in treating Alzheimer's disease

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Two studies show the benefit of collaborative research on childhood blood disorders

Study uncovers the mechanism behind bone marrow failure in Fanconi anemia

Researchers receive $11 million grant to study factors involved in multi-drug resistant infections

CAR NKT cells offer a promising approach to combat hard-to-treat solid tumors

Too little sugar is the cause of perforated bones

Researchers drastically reduce the harvest period of stem cell sheets

New biomarker may help identify patients at risk for graft-versus-host disease after stem cell transplants

New drug offers a promising treatment for neuroblastoma

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

800 million children have high lead levels in their blood

Combinational therapy with antibiotics and stem cells effectively treats bone infections

$9.1 million NCI grant renewal will support researchers studying retrovirus cancer models

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Study reveals how ILCs develop, adapt, specialize in specific tissue environments

NIH awards grants for using bioengineered models to improve clinical trial design

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News